Piperine displays excellent antitumor efficacy against human HER2-overexpressing breast cancer cells through its inhibitory influence on ERK1/2 signaling and blockade of SREBP-1 and FAS expression (Do et al., 2013). The gene discussed is ERBB2; the disease is breast carcinoma.